Vaccine experts advising the FDA have endorsed a new Covid vaccine made by Novavax saying that the shot’s benefits outweigh any risks associated with it.  The vaccine will still need full approval before coming on the market, but it will be the first one available using a more traditional, protein-based technology.  Liz Essley Whyte, reporter at the WSJ, joins us for what to know about its effectiveness and concerns.

<p>Vaccine experts advising the FDA have endorsed a new Covid vaccine made by Novavax saying that the shot&rsquo;s benefits outweigh any risks associated with it.&nbsp; The vaccine will still need full approval before coming on the market, but it will be the first one available using a more traditional, protein-based technology.&nbsp; Liz Essley Whyte, reporter at the WSJ, joins us for what to know about its effectiveness and concerns.</p>

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.

Reopening America

FDA Advisers Back Novavax Vaccine for Authorization

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/226fad64-3f54-4d95-b029-aeae000c293d/transcript